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Introduction
Chronic obstructive pulmonary disease (COPD) is a
prevalent condition and an important cause of morbid-
ity and mortality in Hong Kong. In 2001, about 7.7
people per 1,000 in Hong Kong suffered from COPD and
the mortality rate was 0.32 per 1,000. COPD ranked fifth
after malignant neoplasm, heart diseases, cerebrovascu-
lar disease and pneumonia in a morbidity survey of the
elderly population in 2001 [1].
Patients with COPD are characterized by progressive
airflow obstruction that negatively affects ventilation
and gas exchange and results in dyspnoea on exertion.
Research Report
As the disease progresses further, its impact on both
physical and emotional aspects of life may lead to perma-
nent disability and an impaired mood state [2]. This in
turn influences the quality of life (QOL) for these patients.
Many health-related QOL (HRQOL) questionnaires have
been developed in Western countries; however, few are
applicable to the people of Hong Kong. The major obsta-
cle in adapting a HRQOL questionnaire is the cultural
and language differences between the populations of
Hong Kong and Western countries [3]. According to the
2001 Population Census, about 90% of the people in
Hong Kong speak Cantonese and Mandarin, and only
about 3.2% of the population use English as their usual
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Abstract: The St George’s Respiratory Questionnaire (SGRQ) is a self-administered questionnaire designed to
measure quality of life (QOL) covering three areas (symptoms, activity and impacts) in patients with chronic
obstructive pulmonary disease (COPD). The aim of the present study was to develop a Chinese version of the
SGRQ (SGRQ-HK) and assess its psychometric properties. A forward and back-translation method was used,
which included professional and lay people. Psychometric and clinical evaluations included 54 patients with
COPD (31 males: mean age, 71.22 ( 5.95 years; 23 females: mean age, 68.8 ( 8.64 years). An additional
QOL questionnaire and clinical and physiological data were also collected. The correlation coefficient between
“symptoms” and dyspnoea was 0.67, that between “activity” and the 6-minute walk test was –0.78, between
“impacts” and “mental health” of the SF-36 Health Survey Mental Health Inventory was –0.62; and between
“total” and “general health” of the SF-36 was –0.87. Cronbach’s _ ranged from 0.74 to 0.95 for the whole
questionnaire and its three subscales. Test–retest reliability showed intraclass correlation coefficients of all the
dimensions exceeding 0.70. The three-factor structure of the SGRQ-HK was established. In conclusion, the SGRQ-
HK is reliable and valid and compares well with the original English version.
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language [4]. The translation of HRQOL instruments
into Chinese and testing for validity and reliability are
thus required before an HRQOL survey can be applied to
people in Hong Kong.
The St George’s Respiratory Questionnaire (SGRQ)
was developed by Jones et al in 1992 to measure QOL
among people with COPD [5]. Although a Chinese ver-
sion of the SGRQ for patients with bronchiectasis was
established by Chan et al in 2002 [6], the establishment
of another Chinese version specifically for patients with
COPD is also necessary, as the clinical manifestations
of COPD and bronchiectasis are different [7]. The main
aim of the study was to develop a Hong Kong Chinese
version of the St George’s Respiratory Questionnaire
(SGRQ-HK) for patients with COPD and to examine the
reliability and validity of this translated version.
Methods
Translation procedure
The SGRQ-HK was established by forward and backward
translation in 2000. One professional English–Chinese
translator and one physiotherapist whose first language
was Chinese translated the original English version of
the SGRQ into written Chinese. A panel consisting of
one medical doctor who specialized in respiratory medi-
cine and three physiotherapists who were on the com-
mittee of the Pulmonary Rehabilitation Working Group
of the Coordinating Committee in Physiotherapy of
Hong Kong’s Hospital Authority reviewed the transla-
tions and identified ambiguous items and generated
alternative expressions. The panel consequently devel-
oped the second version of the SGRQ-HK. This version
was then back-translated into English by another inde-
pendent translator and subsequently compared with the
original English version. No major discrepancies be-
tween the back translation and the original version were
found. The only exception was one item in Section 6,
Part 2, that referred to shovelling snow. This item was
deleted from the SGRQ-HK as it was not applicable to
Hong Kong. Other small discrepancies were also re-
solved and a third version was developed. This third
version was then pilot-tested on 20 patients with COPD
for clarity and ease of understanding. No problems were
encountered; therefore, the third version was adopted as
the final version. The reliability and construct validity of
this final version were examined in this study.
Study design
A cross-sectional sample of patients with COPD was
recruited. DesignPowerTM (Statistical Design Analysis
System, 1987; Scientific Software Inc, Pleasanton, CA,
USA) was used for sample-size estimation based on an
estimation of the correlation coefficient in the present
study. With the estimated correlation coefficient be-
tween the sections of the SGRQ-HK and the clinical
variables set at 0.8 and the confidence interval at 95%
(0.97–0.75), the estimated sample size was 50.
The inclusion criteria for the study were inpatients of
Kowloon Hospital with stable COPD who were admitted
at least 2 weeks before the start of the study, a diagnosis
of COPD without other cardiovascular disorders, COPD
of stage I or II according to the staging suggested by the
American Thoracic Society [8], and an ability to under-
stand and speak Cantonese, which is the predominant
dialect of Chinese spoken in Hong Kong.
All patients were stratified according to the severity
of their disease by pulmonary function test (% forced
expiratory volume in 1 second, FEV1) during the base-
line visit. In addition to the SGRQ-HK, a 6-minute walk
test (6MWT), and the Chinese version of the SF-36
Health Survey Mental Health Inventory [9] were ad-
ministered and dyspnoea was scored using the modified
Borg scale. All patients repeated the SGRQ-HK 6 hours
after the baseline assessment and then 2 weeks later to
examine the short- and long-term test–retest reliability,
respectively. The design of the study was approved by
the Ethics Committee of the Kowloon Hospital and the
Human Subjects Subcommittee of the Hong Kong Poly-
technic University.
HRQOL measurements
SGRQ-HK
The SGRQ-HK is a disease-specific assessment tool for
people with COPD. It takes the form of a standardized
questionnaire and can be scored either by health profes-
sionals at interview or by the patients themselves [5].
The SGRQ contains 76 items divided into three sections
consisting of “symptoms”, “activity” and “impacts”. The
symptoms section contains items concerning the level of
symptomatology, including frequency of cough, sputum
production, wheeze and breathlessness, and the dura-
tion and frequency of attacks of breathlessness or wheeze.
The activity section is concerned with physical activities
that cause or are limited by breathlessness. The impacts
section covers a range of aspects concerned with em-
ployment, being in control of health, panic stigmatiza-
tion, the need for medication and its side effects, and ex-
pectation for health and disturbance in daily life.
According to the user manual for the SGRQ, the
weightings for all the subscales with a positive response
are summed. The score is then calculated by dividing
the summed weightings by the maximum possible
weighting for that component. The sum of maximum
possible weightings for the symptoms, activity, impacts
and total scores are 662.5, 1,209.1, 2,117.8 and 3,989.4,
respectively. These weights are the maximum possible
that could be obtained for the worst possible state of
the patient. Thus, a high score indicates poor QOL [5].
The weightings have been collected in six countries:
England, Finland, Holland, Italy, Thailand and the USA.
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Although weightings have not been established in
Hong Kong, there is evidence that nationality has on-
ly a small effect [10]. Therefore, an empirically derived
weighting of each item of the original SGRQ could
confidently be adopted in the present study. The ques-
tionnaire takes approximately 10 minutes to complete.
The SGRQ has been translated into Swedish, Spanish,
Japanese and American-English versions that have been
independently validated for reliability and sensitivity
[11–14].
Chinese version of the SF-36
The SF-36 is a generic HRQOL assessment tool devel-
oped by Ware et al in the USA [9]. It consists of 36 items
grouped under 11 questions. This questionnaire assesses
eight domains of HRQOL over the preceding 4 weeks.
The domains include physical functioning, role limita-
tions due to physical problems, bodily pain, general
health perceptions, vitality, social functioning, role limi-
tation due to emotional problems and general mental
health. The raw scores for each domain are transformed
to a 0–100-point scale such that 0 represents the poor-
est health and 100 the best health. The Chinese (HK)
version of the SF-36 was developed by Lam et al in 1998
through forward and backward translation of the origi-
nal English version. Its reliability, conceptual validity
and construct validity have been established [3].
Physiological measurements
Pulmonary function test
Spirometry was performed using a Vitalograph spirom-
eter (Autospiro AS 500, Osaka, Japan) to measure the
FEV1. The percentage of predicted FEV1 (%FEV1) was
obtained from the recorded FEV1 divided by the FEV1 of
the published norm, with reference to the patient’s gen-
der, age and height [15].
6-minute walk test
The 6MWT was conducted on the basis of the greatest
distance covered by the patient in 6 minutes. Patients
were allowed to rest during the 6 minutes, if necessary
[16]. The distance completed during this time was
recorded. During the test, a stopwatch was used for
timing and a Nellcor Pulse Oximeter NPB-40 (Nellcor
Puritan Bennett Inc, Pleasanton, CA, USA) was used for
spirometry (SpO2) and pulse rate measurement. Each
subject was allowed to perform the test twice to obtain
the best result. The first and second trials were 15
minutes apart so that subjects had enough rest before
attempting the second trial.
Dyspnoea
The modified Borg 10-point scale with a verbal expres-
sion of severity was used to measure the level of per-
ceived dyspnoea [17]. A Chinese translated Borg scale
was used in this study.
Analysis
The internal consistency of each section score of the
SGRQ-HK was assessed using Cronbach’s coefficient _.
An acceptable level of _ for this study was taken as 0.7
or above [18]. To examine the short- and long-term test–
retest reliability, one-way random model of the intraclass
correlation coefficients (ICC) were calculated. The reli-
ability was considered fair to good if ICC _ was between
0.4 and 0.75, and results that exceeded 0.75 were con-
sidered to have excellent reliability [18]. The level of
significance was set at 0.05 for all analyses.
Concurrent validity was examined by comparing the
SGRQ-HK with other external references that could
identify the presence or absence of a particular charac-
teristic [18]. To examine the concurrent validity of the
SGRQ-HK, correlations between the SGRQ-HK and the
SF-36, %FEV1, Borg’s dyspnoea score and the 6MWT
were calculated. It was hypothesized that the symptoms
score of the SGRQ-HK would be highly correlated with
the clinical indicators of severity of COPD; a strong
correlation would be found between the activity score
and the physical component score of the SF-36 or the
6MWT; and a strong correlation would be found be-
tween impacts score and the mental health component
score of the SF-36. Correlation matrices were created
between physiological measurements, SF-36 scores and
SGRQ-HK scores. These included correlation between
the SGRQ-HK scores, %FEV1, Borg’s dyspnoea score
and 6MWT, and the correlation between the SGRQ-HK
scores and the SF-36 subscale scores. The correlation was
considered weak if r ranged from 0.00 to 0.25; an r of
0.25–0.5 was considered a fair degree of relationship;
values of 0.5–0.75 were considered moderate to good,
and values above 0.75 were considered good to excellent
[18]. The level of significance was set at 0.05 for all
analyses.
The construct validity was assessed by performing
principal component analysis (PCA) for the SGRQ-HK. A
correlation matrix of all the items was created. The
factors were extracted for factor analysis by two criteria:
factors with eigenvalues greater than 1 and the Scree test
criterion, obtained by plotting the eigenvalues against
the number of factors. A factor loading greater than 0.30
was considered significant. Orthogonal rotation using
varimax rotation was used for the rotation of factors to
improve the spatial structure of the variables so that
distinct factors would be more visible [19].
Results
Baseline characteristics and SGRQ-HK data are pre-
sented in Table 1. Sixty patients who fulfilled the inclu-
sion criteria were recruited for the study. Six subjects
were not included in the data analysis. Two of them died
during the study period due to an acute exacerbation of
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the disease and four patients were considered unstable
during the study period. Complete data were available
for 54 patients (31 men, 23 women). The mean ages
were 71.2 years ( 5.9 years for males and 65.5 years (
10.2 years for females.
Table 2 presents the scaling properties and reliability
values for the SGRQ-HK. The mean SGRQ-HK symp-
toms score was 59.5 ( 19.8%, the activity score was
62.7 ( 27%, the impacts score was 48.1 ( 22.3%, and the
total score was 51.2 ( 21.7% of the possible maximum
scores. Most of the subjects did not achieve the worst
(“ceiling effect”) or the best (“floor effect”) possible score
for any of the subscales. The one exception was the
activity section, where 11.1% of patients achieved the
worst possible score. Cronbach’s _ was calculated as 0.74
for the symptoms score, 0.92 for the activity score, 0.90
for the impacts score and 0.95 for the total score. The
short-term test–retest reliability of the SGRQ-HK was
excellent, with an ICC ranging from 0.97 to 0.98 (p <
0.001). The long-term test–retest reliability was also
good, with an ICC ranging from 0.70 to 0.86.
Table 3 shows the pattern of correlations between the
SGRQ-HK scores and other validated external references.
The SGRQ-HK scores showed significant correlations
with those references that measured similar underlying
dimensions (convergent validity) and weaker correla-
tion with other variables that were not directly related
(discriminant validity).
Construct validity was established by performing
factor analysis on the SGRQ-HK data. Based on the
criterion of an eigenvalue of more than 1, the data
yielded 13 factors and explained almost 88% of variance.
When the factors were further extracted using a Scree
plot, a maximum of three factors were extracted. These
three factors accounted for 52% of the variance in the
data. The first factor showed positive correlations with 5
of the 8 symptoms items, 10 of the 16 activity items, and
13 of the 26 impacts items. We labelled it “physical
activity” because many of the items were asking about
exercise and activities. The second factor showed posi-
tive correlations with 3 of the 8 symptoms items, 3 of the
16 activity items, and 3 of the 26 impacts items. Since the
Table 1. Baseline characteristics and scores on the Hong Kong Chinese version of the St George’s Respiratory
Questionnaire (SGRQ-HK) and SF-36 Health Survey Mental Health Inventory (SF-36) (n = 54)
Patient characteristics Mean ( SD HRQOL scores Mean ( SD
Age (yr) 68.8 ( 8.41 SF-36
%FEV
1
49.7 ( 14.0    Physical functioning 45.1 ( 31.3
6MWT (m) 285.7 ( 33.41    Role physical 36.1 ( 39.7
   Bodily pain 76.4 ( 20.1
SGRQ-HK    General health 41.7 ( 28.9
   Symptoms 59.5 ( 19.8    Vitality 40.4 ( 17.0
   Activity 62.7 ( 26.0    Social functioning 59.1 ( 33.7
   Impacts 48.1 ( 22.3    Role emotion 47.5 ( 46.5
   Total 51.2 ( 21.7    Mental health 52.2 ( 33.5
SD = standard deviation; HRQOL = health-related quality of life; %FEV
1
 = % forced expiratory volume in 1 second; 6MWT = 6-minute walk
test.
Table 2. Results of scaling properties and reliability of the Hong Kong Chinese version of the St George’s
Respiratory Questionnaire (SGRQ-HK)
Symptoms Activity Impacts Total
Number of items (n) 8 16 26 50
Scales levels (n) 29 16 31 76
Incomplete rate, % 0 0 0 0
Theoretical range 0–100 0–100 0–100 0–100
Observed range 22.5–97.4 11.21–100 10.8–92 9.7–85.3
Percentage at ceiling score 0 11.1 0 0
Percentage at floor score 0 0 0 0
Cronbach’s _ 0.74 0.92 0.90 0.95
Short-term test–retest reliability (r) 0.97 0.97 0.97 0.98
Long-term test–retest reliability (r) 0.77 0.86 0.78 0.70
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symptoms items contributed more in proportion, this
factor was labelled “symptoms”. The third factor showed
positive correlations with the two activity items and 10
impacts items and was therefore labelled “impacts”. The
three-factor structure of the SGRQ-HK was established.
Discussion
This study examined the measurement properties of the
SGRQ-HK for patients with COPD. The study has shown
that the SGRQ-HK is a reliable and valid instrument that
can be used to assess QOL in Hong Kong Chinese people
with COPD. Although Chan et al recently conducted a
similar study to examine the validity of a Chinese ver-
sion of the SGRQ for bronchiectasis [6], assessing the
reliability and validity of the questionnaire with COPD
was also needed for several reasons. Firstly, bronchiecta-
sis is a less common form of obstructive lung disease than
COPD, both locally and worldwide [7]. Secondly, the
underlying pathology of the two diseases is different.
As a result, the clinical presentations of COPD and
bronchiectasis are also different. For patients with COPD,
disabling dyspnoea, wheeze, cough and sputum pro-
duction are the common symptoms, whereas dyspnoea,
chest pain and large quantities of purulent sputum
production are more common in patients with bron-
chiectasis [7]. Thirdly, the sample characteristics of sub-
jects recruited in the present study were more similar to
the sample of the original study. Thus, the SGRQ-HK
established in the present study would be more appro-
priate for assessing QOL in patients with COPD.
The SGRQ-HK showed high internal consistency,
with the Cronbach’s _ of all subscales exceeding 0.7.
These results are comparable to the studies of Engström
et al [11] and Ferrer et al [12] in the development of the
Swedish and Spanish versions of the SGRQ. The internal
consistency was also much higher than found by Chan et
al, who found Cronbach’s _ of 0.59–0.92. In our study,
the short-term test–retest reliability of the SGRQ-HK
was extremely high. Such high reliability reflects that
the SGRQ-HK is stable and reliable for repeated mea-
surements over a short period of time. As no similar
short-term studies have been conducted in the past, the
result cannot be compared with previous studies. The
result was also satisfactory for long-term test–retest
reliability. The lower test–retest reliability in our study,
when compared with the original version and the study
of Chan et al, might have resulted from a less stringent
criterion for identifying stable patients and somewhat
smaller sample size.
Although one item in Section 6, Part 2, was deleted
from the SGRQ-HK, the content validity of the SGRQ-
HK was not formally assessed in this study. On the other
hand, the concurrent validity of the SGRQ-HK was es-
tablished. We have shown that the SGRQ-HK correlated
significantly with a number of measures of disease se-
verity and activities relevant to people with COPD. The
symptoms score was significantly correlated to items of
symptomatology consistent with COPD such as breath-
lessness and low lung-function test scores. These results
were comparable with those from studies conducted by
Chan et al and Engström et al [6,11]. However, signifi-
cant and stronger correlations were found between the
Table 3. Pearson’s product moment correlation coefficients between the Hong Kong Chinese version of the
St George’s Respiratory Questionnaire total and component scores and clinical variables and component
scores of the SF-36 Health Survey Mental Health Inventory (SF-36)
Correlation coefficient, r
Symptoms Activity Impacts Total
%FEV
1
–0.54* –0.59* –0.43* –0.6*5
Dyspnoea score –0.67* –0.68* –0.44* –0.79*
6MWT (m) –0.73* –0.78* –0.49* –0.75*
SF-36 Physical functioning –0.65* –0.90* –0.64* –0.86*
SF-36 Role physical –0.39* –0.59* –0.41† –0.56*
SF-36 Bodily pain –0.39* –0.49* –0.45* –0.49‡
SF-36 General health –0.71* –0.92* –0.61† –0.87*
SF-36 Vitality –0.62* –0.73* –0.56† –0.75*
SF-36 Social functioning –0.60* –0.80* –0.66† –0.79*
SF-36 Role emotion –0.45* –0.31‡ –0.33‡ –0.40‡
SF-36 Mental health –0.58* –0.59* –0.62* –0.68*
*Correlation significant at the 0.001 level (2-tailed); †correlation significant at the 0.01 level (2-tailed); ‡Correlation significant at the 0.05 level
(2-tailed). %FEV
1
 = % forced expiratory volume in 1 second; 6MWT = 6-minute walk test.
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symptoms score and the dyspnoea score and lung func-
tion in the original study [5]. This discrepancy could
have come about because the original study also in-
cluded people with asthma. In addition, the SGRQ-HK
activity score was most strongly associated with exercise
tolerance performance, as measure by the 6MWT and
the physical component of the SF-36. The activity score
was also moderately correlated with the dyspnoea score
and spirometry. These findings were observed in the
studies conducted by Jones et al, Engström et al and
Ferrer et al [5,11,12], except that good correlation was
found between the activity score and the Medical Re-
search Council dyspnoea grade in the original study.
However, only moderate correlation with the activity
score and 6MWT was observed by Chan et al [6]. This
can be explained because they recruited patients
with bronchiectasis and good exercise tolerance who
showed less limitation in their physical activities. This is
also reflected by their relatively high floor percentage
in the activity score (11.7%) [6]. The impacts score of the
SGRQ-HK was moderately correlated with the mental
health component of the SF-36. Our result was similar to
the study of Chan et al, except that a higher correlation
with the mental health component of the SF-36 was
found in our study. The total score is intended to reflect
all aspects of the patient’s health impairment. It corre-
lated significantly with all the domains of the SF-36. This
was expected because the SF-36 is a measure of overall
subjective well-being and social functioning, and this
instrument is complementary to the SGRQ-HK in the
assessment of patients with COPD.
The original developers of the SGRQ conducted PCA,
which supported the partition of the questionnaire into
three sections [5]. However, little information was pub-
lished concerning item generation and the PCA results
of the original SGRQ. Our study tried to replicate this re-
sult by performing PCA on the SGRQ-HK. An impor-
tant step in factor analysis is to determine the number
of factors that are to be extracted. One of the most wide-
ly used approaches is the eigenvalues greater than 1 rule
[19,20]. In the present study, 13 factors were extrac-
ted under this rule (explaining 87.57% of variance).
Another widely used method is the Scree plot, and
three factors were extracted in this process (explaining
52.26% of variance). The three factors were closely re-
lated to the original domains of the SGRQ (symptoms,
physical activity and impacts compared with symptoms,
activity and impacts). However, the proportion of the
variance of the SGRQ-HK that was explained by the
model fell from 87.57% to 52.26% if three instead of 13
factors were extracted. In addition, 22% of the items
(11 of 50 items) of the SGRQ-HK had a factor loading be-
low ( 0.3, indicating that some of the items were weak-
ly correlated with the domains. Similar results were ob-
served by Rutten-van Mölken et al [21]. In their study,
almost 50% of the items of the SGRQ had a factor loading
below 0.4, indicating a lack of homogeneity [21]. One
possible reason was the small sample size in both our
study and that of Rutten-van Mölken et al. In factor
analysis, when the factor structure is being explored, a
small sample size may lead to large standard errors for
the estimated parameters. This may result in incorrect
estimation of both the number of factors and the struc-
ture of the factors [21]. As recommended by Hair et al
[19], a minimum number of subjects of five or 10 times
the number of observed variables should be recruited for
the study. Thus, a minimum of 250 subjects would be
required to perform factor analysis for the SGRQ.
Conclusion
Our results suggest that the SGRQ-HK is a valid measure
to assess QOL in Chinese people with COPD. Moreover,
this study has also shown that the SGRQ-HK has good
repeatability, producing consistent scores in patients
with a stable condition over a short period of time, as
well as good internal consistency when applied to such
a group of patients. However, the factor structure of the
SGRQ-HK is still unclear and further study in this area is
required.
Acknowledgements
The authors acknowledge the patients who participated
in this study, and Dr. Alice Jones, Dr. Gladys Cheing and
Mr. Raymond Tsang for their expert advice and com-
ments.
References
1. Hong Kong Hospital Authority. http:// www.ha.org.hk [Date
accessed: 14 April 2004.]
2. Pauwels RA, Buist AS, Calverley PMA, et al. Global strategy
for the diagnosis, management, and prevention of chronic
obstructive pulmonary disease. Am J Respir Crit Care Med 2001;
163:1256–76.
3. Lam CLK, Gandek B, Ren XS, et al. Tests of scaling assump-
tions and construct validity of the Chinese (HK) version of the
SF-36 Health Survey. J Clin Epidemiol 1998;51:1139–47.
4. Census and Statistics Department. http://www.info.gov.hk/
censtatd/ [Date accessed: 20 April 2004.]
5. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete
measure of health status for chronic airflow limitation – the
St George’s Respiratory Questionnaire. Am Rev Respir Dis
1992;145:1321–7.
6. Chan SL, Chan-Yueng MM, Ooi GC, et al. Validation of the
Hong Kong Chinese version of the St George respiratory
questionnaire in patients with bronchiectasis. Chest 2002;6:
2030–7.
7. Ryu JH, Scanlon PD. Obstructive lung diseases: COPD, asthma,
and many imitators. Mayo Clin Proc 2001;11:1144–53.
39Hong Kong Physiotherapy Journal • Volume 22 • 2004
8. ATS Statement. Standards for the diagnosis and care of
patients with chronic obstructive pulmonary disease. Am J
Respir Crit Care Med 1995;152:s83.
9. Ware JE, Snow KK, Kosinski M, et al. SF-36 Health Survey –
Manual and Interpretation Guide. Boston: The Health Institute,
New England Medical Center, 2000;1:1–4:8.
10. Quirk FH, Baveystock CM, Wilson RC, et al. Influence of
demographic and disease related factors on the degree of dis-
tress associated with symptoms and restrictions on daily liv-
ing due to asthma in six countries. Eur Respir J 1991;4:167–71.
11. Engström CP, Persson LO, Larsson S, et al. Reliability and
validity of a Swedish version of the St George’s Respiratory
Questionnaire. Eur Respir J 1998;11:61–6.
12. Ferrer M, Alonso J, Prieto L, et al. Validity and reliability of the
St George’s Respiratory Questionnaire after adaptation to a
different language and culture: the Spanish example. Eur
Respir J 1996;9:1160–6.
13. Hajiro T, Nishimura K, Tsukino M, et al. Comparison of
discriminative properties among disease-specific question-
naires for measuring health-related quality of life in patients
with chronic obstructive pulmonary disease. Am J Respir Crit
Care Med 1998;157:785–90.
14. Barr JT, Schumacher GE, Freeman S, et al. American transla-
tion, modification, and validation of St George’s Respiratory
Questionnaire. Clin Ther 2000;22:1121–45.
15. Cotes JE. Lung Function: Assessment and Application in Medicine,
5th edition. Oxford: Blackwell Scientific Publications, 1993:
445–513.
16. ATS Statement. Guidelines for the six-minute walk test. Am J
Respir Crit Care Med 2002;166:111–7.
17. Borg G. Psychological basis of perceived exertion. Med Sci
Sports Exerc 1982;14:377–81.
18. Portney LG, Watkins MP. Foundations of Clinical Research:
Application and Practice, 2nd edition. Norwalk, Connecticut:
Appleton & Lange, 2000:441–2.
19. Hair JF, Anderson RE, Tatham RL, et al. Multivariate Analysis,
6th edition. Upper Saddle River, NJ: Prentice Hall, 2002:482–
514.
20. Fayers PM, Machin D. Quality of Life: Assessment, Analysis and
Interpretation. Chichester: John Wiley, 2000:273–325.
21. Rutten-van Mölken M, Roos B, Van Noord JA. An empirical
comparison of the St George’s Respiratory Questionnaire
(SGRQ) and the Chronic Respiratory Disease Questionnaire
(CRQ) in a clinical trial setting. Thorax 1999;54:995–1003.
